Currently, there are 1.47M common shares owned by the public and among those 1.38M shares have been available to trade.
The company’s stock has a 5-day price change of 51.85% and -54.80% over the past three months. SXTP shares are trading -55.50% year to date (YTD), with the 12-month market performance down to -82.61% lower. It has a 12-month low price of $1.41 and touched a high of $35.99 over the same period. SXTP has an average intraday trading volume of 460.24K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 49.39%, 24.19%, and -53.63% respectively.
Institutional ownership of 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) shares accounts for 2.08% of the company’s 1.47M shares outstanding.
It has a market capitalization of $4.23M and a beta (3y monthly) value of 2.19. The earnings-per-share (ttm) stands at -$27.07. Price movements for the stock have been influenced by the stock’s volatility, which stands at 26.11% over the week and 14.53% over the month.
Analysts forecast that 60 Degrees Pharmaceuticals Inc (SXTP) will achieve an EPS of -1.32 for the current quarter, -1.28 for the next quarter and -5.72 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -1.32 while analysts give the company a high EPS estimate of -1.32. Comparatively, EPS for the current quarter was -7.88 a year ago. Earnings per share for the fiscal year are expected to increase by 81.77%, and 13.65% over the next financial year. EPS should grow at an annualized rate of 71.59% over the next five years, compared to 12.29% over the past 5-year period.
